NPCE - Neuropace - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NPCE is currently covered by 4 analysts with an average price target of $20.15. This is a potential upside of $4.27 (26.89%) from yesterday's end of day stock price of $15.88.

Neuropace's activity chart (see below) currently has 73 price targets and 45 ratings on display. The stock rating distribution of NPCE is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 61.24% with an average time for these price targets to be met of 118.57 days.

Highest price target for NPCE is $17, Lowest price target is $15, average price target is $16.

Most recent stock forecast was given by VIK CHOPRA from WELLS FARGO on 13-Aug-2025. First documented stock forecast 17-May-2021.

Currently out of the existing stock ratings of NPCE, 7 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$15

$-1.36 (-8.31%)

$13

4 months 3 days ago
(13-Aug-2025)

3/3 (100%)

$5.68 (60.94%)

149

Buy

$16

$-0.36 (-2.20%)

$14

7 months 2 days ago
(14-May-2025)

4/5 (80%)

$0.4 (2.56%)

127

Buy

$17

$0.64 (3.91%)

$17

7 months 2 days ago
(14-May-2025)

5/6 (83.33%)

$1.4 (8.97%)

150

Buy

$20

$3.64 (22.25%)

$20

1 years 7 months 10 days ago
(06-May-2024)

3/5 (60%)

$6.53 (48.48%)

121

Buy

$20

$9.8 (96.08%)

$16

1 years 9 months 2 days ago
(14-Mar-2024)

5/8 (62.5%)

$6.37 (46.74%)

266

Show more analysts

Please expand the browser size to see the chart

What is NPCE (Neuropace) average time for price targets to be met?

On average it took 118.57 days on average for the stock forecasts to be realized with a an average price target met ratio 61.24

Which analyst has the current highest performing score on NPCE (Neuropace) with a proven track record?

ROSS OSBORN

Which analyst has the current lower performing score on NPCE (Neuropace) with a proven track record?

MIKE POLARK

Which analyst has the most public recommendations on NPCE (Neuropace)?

Ross Osborn works at CANTOR FITZGERALD and has 11 price targets and 8 ratings on NPCE

Which analyst is the currently most bullish on NPCE (Neuropace)?

Mike Polark with highest potential upside - $11.39

Which analyst is the currently most reserved on NPCE (Neuropace)?

Vik Chopra with lowest potential downside - -$1.36

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?